9PDE | pdb_00009pde

Three-dimensional structure of kinase inhibitor Palbociclib-HIV TAR complex


SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-1H TOCSY0.9 mM HIV TAR RNA (29-MER)90% H2O/10% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm278Bruker AVANCE III 800
22D 1H-1H NOESY0.9 mM HIV TAR RNA (29-MER)90% H2O/10% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm278Bruker AVANCE III 800
32D 1H-1H TOCSY0.9 nM HIV TAR RNA (29-MER)100% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm298Bruker AVANCE III 800
42D 1H-1H NOESY0.9 nM HIV TAR RNA (29-MER)100% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm298Bruker AVANCE III 800
52D 1H-1H TOCSY0.9 mM HIV TAR RNA (29-MER)100% D2O20 mM sodium acetate mM5.01 atm298Bruker AVANCE III 800
282D 1H-1H NOESY0.9 mM HIV TAR RNA (29-MER)100% D2O20 mM sodium acetate mM5.01 atm298Bruker AVANCE III 800
272D 1H-13C HMQC0.25 mM [U-99% 13C; U-99% 15N] HIV TAR RNA (29-MER)100% D2O20 mM sodium acetate mM5.01 atm298Bruker AVANCE III 800
262D 1H-13C CT-HSQC aliphatic0.25 mM [U-99% 13C; U-99% 15N] HIV TAR RNA (29-MER)100% D2O20 mM sodium acetate mM5.01 atm298Bruker AVANCE III 800
252D 1H-13C CT-HSQC aromatic0.25 mM [U-99% 13C; U-99% 15N] HIV TAR RNA (29-MER)100% D2O20 mM sodium acetate mM5.01 atm298Bruker AVANCE III 800
242D 1H-1H filtered NOESY0.25 mM [U-99% 13C; U-99% 15N] HIV TAR RNA (29-MER)100% D2O20 mM sodium acetate mM5.01 atm298Bruker AVANCE III 800
232D 1H-15N HSQC0.25 mM [U-99% 13C; U-99% 15N] HIV TAR RNA (29-MER)95% H2O/5% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm278Bruker AVANCE III 800
222D 1H-15N HSQC NH2 only0.25 mM [U-99% 13C; U-99% 15N] HIV TAR RNA (29-MER)95% H2O/5% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm278Bruker AVANCE III 800
212D 1H-15N HNNCOSY0.25 mM [U-99% 13C; U-99% 15N] HIV TAR RNA (29-MER)95% H2O/5% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm278Bruker AVANCE II 600
202D 1H-1H TOCSY0.9 mM [U-99% 2H] HIV TAR RNA (29-MER)100% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm298Bruker AVANCE III 800
192D 1H-1H NOESY0.9 mM [U-99% 2H] HIV TAR RNA (29-MER)100% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm298Bruker AVANCE III 800
182D 1H-1H NOESY0.9 mM [U-99% 2H] HIV TAR RNA (29-MER)90% H2O/10% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm278Bruker AVANCE III 800
172D 1H-1H TOCSY0.35 mM [U-99% 2H] HIV TAR RNA (29-MER)90% H2O/10% D2O20 sodium acetate mM5.01 atm298Bruker AVANCE III 800
162D 1H-1H NOESY0.35 mM [U-99% 2H] HIV TAR RNA (29-MER)90% H2O/10% D2O20 sodium acetate mM5.01 atm298Bruker AVANCE III 800
152D 1H-1H NOESY0.35 mM [U-99% 2H] HIV TAR RNA (29-MER)100% D2O20 mM bis tris d19, 50 mM sodium chloride mM5.81 atm278Bruker AVANCE III 800
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE NEO500
2BrukerAVANCE II600
3BrukerAVANCE III800
NMR Refinement
MethodDetailsSoftware
simulated annealingX-PLOR NIH
NMR Ensemble Information
Conformer Selection Criteriastructures with the lowest energy
Conformers Calculated Total Number200
Conformers Submitted Total Number10
Representative Model1 (lowest energy)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1collectionTopSpinBruker Biospin
2processingTopSpinBruker Biospin
3chemical shift assignmentSparkyGoddard
4structure calculationX-PLOR NIHSchwieters, Kuszewski, Tjandra and Clore
5refinementX-PLOR NIHSchwieters, Kuszewski, Tjandra and Clore